Konstantin H Dragnev

5PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 04, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|Jul 17, 2024
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.

Stephanie J Bouley, Andrew V Grassetti, Robert J Allaway

|Jun 17, 2024
Biomarker-Driven Personalized Immunoprevention: Toward More Efficient Clinical Trials?

Sai Yendamuri, Konstantin H Dragnev

|Jul 19, 2023
Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines.

Konstantin H Dragnev, Ronald A Lubet, Mark Steven Miller

|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).

Shirish M Gadgeel, Jieling Miao, Jonathan W Riess

Pageof 1